| J0897 | Injection, denosumab, 1 mg | 26,700 | $20 | $480.6K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 36,960 | $10 | $295.7K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,700 | $30 | $261.8K |
| J3262 | Injection, tocilizumab, 1 mg | 40,400 | $10 | $202K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 48,800 | $1 | $195.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,840 | $100 | $183.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 1,160 | $60 | $68.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 920 | $70 | $61.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,100 | $10 | $41K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 930 | $30 | $26.9K |